Biotech

All Articles

BioAge eyes $180M coming from IPO, private positioning for obesity trials

.BioAge Labs is checking out about $180 million in initial earnings from an IPO and also a private p...

Merck's LAG-3 combination falls short colorectal cancer phase 3 research study

.An attempt by Merck &amp Co. to unlock the microsatellite steady (MSS) metastatic colon cancer cell...

Spanish VC finalizes $200M life scientific researches fund

.Spain-based Asabys Partners has closed a fund of 180 thousand euros ($ 200 million), cash that will...

BioAge generates $198M from IPO as weight problems biotech participates in Nasdaq

.BioAge Labs is actually generating virtually $200 million through its own Nasdaq IPO this morning, ...

Acadia carries BMS veterinarian on board as chief executive officer-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of considerable management hirings, shooting...

Cassava pays for $40M over presumably misleading Alzheimer's update

.Cassava Sciences has actually accepted to pay out $40 thousand to solve an examination into cases i...

Merck bags choices on Evaxion's AI-designed injection prospects

.Merck &amp Co. has actually picked up options on 2 Evaxion Biotech vaccination prospects, paying ou...

Enanta's RSV antiviral crushes popular load in difficulty research

.Enanta Pharmaceuticals has connected its breathing syncytial infection (RSV) antiviral to notable d...

Biogen cans SAGE-324 collaboration after necessary agitation neglect

.Biogen has actually carried out the last ceremonies to its own cooperation with Sage Rehabs on SAGE...

AbbVie Parkinson's medicine from $8.7 B Cerevel purchase ratings

.On the very same time that some Parkinson's illness drugs are actually being brought into question,...